These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17496448)

  • 1. [Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].
    Hattori Y; Takizawa A; Kishida T; Kakizoe M; Fujikawa N; Teranishi J; Kondo K; Saito K; Noguchi K; Nakaigawa N; Kubota Y
    Gan To Kagaku Ryoho; 2007 May; 34(5):739-43. PubMed ID: 17496448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
    Tsavaris N; Kosmas C; Skopelitis H; Dimitrakopoulos A; Kopterides P; Bougas D; Stravodimos K; Mitropoulos D; Alamanis C; Giannopoulos A
    J Chemother; 2005 Aug; 17(4):441-8. PubMed ID: 16167525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z; Dimopoulos MA; Kostakopoulos A; Karayiannis A; Sofras F; Zervas A; Giannopoulos A; Dimopoulos C
    J Urol; 1997 Aug; 158(2):408-11. PubMed ID: 9224313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
    Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
    Kouno T; Ando M; Yonemori K; Matsumoto K; Shimizu C; Katsumata N; Komiyama M; Okajima E; Matsuoka N; Fujimoto H; Fujiwara Y
    Eur Urol; 2007 Oct; 52(4):1115-22. PubMed ID: 17433855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
    Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Kume T; Masu C; Ishino T; Nakatsu H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2577-82. PubMed ID: 2673046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].
    Sella A; Flex D; Gafni D; Rabinovitz O; Sulkes A; Baniel J
    Harefuah; 1999 Feb; 136(4):268-71, 340, 339. PubMed ID: 10914214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of modified M-VAC therapy with one 21-day cycle for advanced urothelial cancer].
    Nakanishi S; Matsuzaki M; Morikawa H; Nakano M; Komatsu H
    Hinyokika Kiyo; 2004 Oct; 50(10):667-71. PubMed ID: 15575216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).
    Lehmann J; Retz M; Wiemers C; Beck J; Thüroff J; Weining C; Albers P; Frohneberg D; Becker T; Funke PJ; Walz P; Langbein S; Reiher F; Schiller M; Miller K; Roth S; Kälble T; Sternberg D; Wellek S; Stöckle M;
    J Clin Oncol; 2005 Aug; 23(22):4963-74. PubMed ID: 15939920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
    Cao W; Xu C; Lou G; Jiang J; Zhao S; Geng M; Xi W; Li H; Jin Y
    Jpn J Clin Oncol; 2009 Sep; 39(9):582-7. PubMed ID: 19509000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paclitaxel, ifosfamide, nedaplatin (TIN) for patients with metastatic urothelial cancer].
    Suzuki S; Shinohara N; Harabayashi T; Seki H; Murakumo M; Ishikawa R; Demura T; Mitsuhashi K; Toyota H; Koyanagi T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):561-5. PubMed ID: 15114700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of neoadjuvant chemotherapy for invasive bladder cancer with MEC (methotrexate, epirubicin, cisplatin) therapy].
    Ohuchi H; Noguchi S; Takase K; Kawakami S; Ikeda I; Saito K; Yao M; Masuda M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 2001 Apr; 47(4):241-6. PubMed ID: 11411097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer].
    Mikami K; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Nakao M
    Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH; Shi YX; Guan ZZ; Jiang WQ; Huang H; Ma ZY; Wang JH; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
    Papadimitriou CA; Bafaloukos D; Bozas G; Kalofonos H; Kosmidis P; Aravantinos G; Fountzilas G; Dimopoulos MA;
    Gynecol Oncol; 2008 Jul; 110(1):87-92. PubMed ID: 18455782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
    Hirose T; Sugiyama T; Kusumoto S; Shirai T; Nakashima M; Yamaoka T; Okuda K; Ogura K; Ohnishi T; Ohmori T; Adachi M
    Anticancer Res; 2009 May; 29(5):1733-8. PubMed ID: 19443395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome of treatment with surgical resection of the remaining tumor after modified M-VAC treatment for advanced urothelial carcinoma].
    Narita S; Nakano M; Matsuzaki M; Watanabe J; Morikawa H; Murata H; Oda H; Komatsu H
    Hinyokika Kiyo; 2005 Mar; 51(3):155-8. PubMed ID: 15852667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies of chemotherapy for patients with a solitary kidney after nephroureterectomy for advanced upper urothelial transitional cell carcinoma].
    Tsujimura A; Takayama H; Tsukikawa M; Imazu T; Sugao H; Takaha M
    Hinyokika Kiyo; 1995 Mar; 41(3):183-9. PubMed ID: 7741070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.
    Oh WK; Manola J; Richie JP; Loughlin KR; Kantoff PW
    Cancer; 1999 Oct; 86(7):1329-34. PubMed ID: 10506721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H; Tada Y; Nakano E; Matsuda M; Osafune M; Sagawa S; Takaha M; Sonoda T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.